Observations on the presence of E domain variants of estrogen receptor-α in the breast tumors

Journal of Surgical Oncology

Volumn 94, Issue 4, 2006, Pages 332-337

  Kumar, Vijay L ^a   Kumar, Suresh ^a   Srivastava, Anurag ^a   Kumar, Vijay ^b  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

^b INTERNATIONAL CENTRE FOR GENETIC ENGINEERING AND BIOTECHNOLOGY   (Italy)

Author keywords

Breast cancer; Estrogen receptor; RT PCR; Splice variants

Indexed keywords

EPITOPE; ESTROGEN RECEPTOR ALPHA;

ARTICLE; BREAST CANCER; BREAST TUMOR; CLINICAL ARTICLE; ENZYME LINKED IMMUNOSORBENT ASSAY; EXON; GENE DELETION; HORMONE BINDING; HUMAN; IMMUNOREACTIVITY; LYMPH NODE METASTASIS; PRIORITY JOURNAL; PROGNOSIS; PROTEIN DOMAIN; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 33748327052     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1016/j.cose.2005.11.004     Document Type: Article

References (41)

1. Lacey JV, Jr. Devesa SS, Brinton LA: Recent trends in breast cancer incidence and mortality. Environ Mol Mutagen 2002;39:82-88.
2. Rao DN, Ganesh B: Estimation of cancer incidence in India in 1991. Ind J Cancer 1998;35:10-18.
3. Chopra R: The Indian scene. J Clin Oncol 2001;19:1068-111S.
4. Kirschner MA: The role of hormones in the etiology of human breast cancer. Cancer 1977;39:2716S-2726S.
5. Robertson JF: Oestrogen receptor: A stable phenotype in breast cancer. Br J Cancer 1996;73:5-12.
6. Iwase H: Molecular action of the estrogen receptor and hormone dependency in breast cancer. Breast Cancer 2003;10:89-96.
7. Locker GY: Hormonal therapy for breast cancer. Cancer Treat Rev 1998;24:221-240.
8. Kumar VL, Srivastava A, Singhal R, et al.: Immunoreactive estrogen receptor in breast tumor and adjacent tissue: Association with clinicopathological characteristics in Indian population. J Surg Oncol 2005;89:251-255.
9. McGuire WL, Chamness GC, Fuqua SA: Estrogen receptor variants in clinical breast cancer. Mol Endocrinol 1991;5:1571-1577.
10. Watts CK, Handel ML, King RJ, et al.: Oestrogen receptor gene structure and function in breast cancer. Mol Biol 1992;41:529-536.
11. Ricketts D, Turnbull L, Ryall G, et al.: Estrogen and progesterone receptors in the normal female breast. Cancer Res 1991;51:1817-1822.
12. Palmieri C, Cheng GJ, Saji S, et al.: Estrogen receptor beta in breast cancer. Endocr Relat Cancer 2002;9:1-13.
13. Shaaban AM, O'Neill PA, Davies MP, et al.: Declining estrogen receptor-beta expression defines malignant progression of human breast neoplasia. Am J Surg Pathol 2003;27:1502-1512.
14. Roger P, Sahla ME, Makela S, et al.: Decreased expression of estrogen receptor beta protein in proliferative preinvasive mammary tumors. Cancer Res 2001;61:2537-2541.
15. Ponglikitmongkol M, Green S, Chambon P: Genomic organization of the human oestrogen receptor gene. EMBO J 1988;7:3385-3388.
16. Kumar V, Green S, Stack G, et al.: Functional domains of the human estrogen receptor. Cell 1987;51:941-951.
17. Snead DR, Bell JA, Dixon AR, et al.: Methodology of immunohistological detection of oestrogen receptor in human breast carcinoma in formalin-fixed, paraffin-embedded tissue: A comparison with frozen section methodology. Histopathology 1993;23:233-238.
18. Huang A, Leygue ER, Dotzlaw H, et al.: Influence of estrogen receptor variants on the determination of ER status in human breast cancer. Breast Cancer Res Treat 1999;58:219-225.
19. Dowsett M, Daffada A, Chan CM, et al.: Oestrogen receptor mutants and variants in breast cancer. Eur J Cancer 1997;33:1177-1183.
20. Leclercq G: Molecular forms of the eslrogen receptor in breast cancer. J Steroid Biochem Mol Biol 2002;80:259-272.
21. Poola I, Speirs V: Expression of alternatively spliced estrogen receptor alpha mRNAs is increased in breast cancer tissues. J Steroid Biochem Mol Biol 2001;78:459-469.
22. Zhang QX, Hilsenbeck SG, Fuqua SA. et al.: Multiple splicing variants of the estrogen receptor are present in individual human breast tumors. J Steroid Biochem Mol Biol 1996;59:251-260.
23. Koehorst SG, Cox JJ, Donker GH, et al.: Functional analysis of an alternatively spliced estrogen receptor lacking exon 4 isolated from MCF-7 breast cancer cells and meningioma tissue. Mol Cell Endocrinol 1994;101:237-245.
24. Fuqua SA, Fitzgerald SD, Aldred DC, et al.: Inhibition of estrogen receptor action by a naturally occurring variant in human breast tumors. Cancer Res 1992;52:483-486.
25. Fuqua SA, Fitzgerald SD, Chamness GC, et al.: Variant human breast tumor estrogen receptor with constitutive transcriptional activity. Cancer Res 1991;51:105-109.
26. Omoto Y, Iwase H, Iwata H, et al.: Expression of estrogen receptor alpha exon 5 and 7 deletion variant in human breast cancers. Breast Cancer 2000;7:27-31.
27. Garcia Pedrero JM, Zuazua P, Martinez-Campa C, et al.: The naturally occurring variant of estrogen receptor (ER) ERDeltaE7 suppresses estrogen-dependent transcriptional activation by both wild-type ERalpha and ERbeta. Endocrinology 2003;144:2967-2976.
28. Chappell SA, Johnson SM, Shaw JA, et al.: Expression of oestrogen receptor alpha variants in non-malignant breast and early invasive breast carcinoma. J Pathol 2000;192:159-165.
29. Leygue E, Dotzlaw H, Watson PH, et al.: Altered expression of estrogen receptor-α variant messenger RNAs between adjacent normal breast and breast cancer tissue. Breast Cancer Res 1999;2:64-72.
30. Meegan MJ, Lloyd DG: Advances in the science of estrogen receptor modulation. Curr Med Chem 2003;10:181-210.
31. Bradford MM: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976;72:248-254.
32. Chomczynski P, Sacchi N: Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987;162:156-159.
33. Saegusa M, Hashimura M, Hara A, et al.: Loss of expression of the gene deleted in colon carcinoma (DCC) is closely related to histologic differentiation and lymph node metastasis in endometrial carcinoma. Cancer 1999;85:453-464.
34. Poola I, Koduri S, Chatra S, et al.: Identification of twenty alternatively spliced estrogen receptor alpha mRNAs in breast cancer cell lines and tumors using splice targeted primer approach. J Steroid Biochem Mol Biol 2000;72:249-258.
35. Poola I, Clarke R, Dewitty R, et al.: Functionally active estrogen receptor isoform profiles in the breast tumors of African American women are different from the profiles in breast tumors of Caucasian women. Cancer 2002;94:615-623.
36. Leygue ER, Huang A, Murphy LC, et al.: Prevalence of estrogen receptor variant messenger RNAs in human breast cancer. Cancer Res 1996;56:4324-4327.
37. Henry JA, Nicholson S, Farndon JR, et al.: Measurement of oestrogen receptor niRNA levels in human breast tumours. Br J Cancer 1988;58:600-605.
38. Pavao M, Traish AM: Estrogen receptor antibodies: Specificity and utility in detection, localization and analyses of estrogen receptor alpha and beta. Steroids 2001;66:1-16.
39. Kuukasjrvi T, Kononen J, Helim H, et al.: Loss of estrogen receptor in recurrent breast cancer is associated with poor response to endocrine therapy. J Clin Oncol 1996;14:2584-2589.
40. Horvath G, Leser G, Helou K, et al.: Function of the exon 7 deletion variant estrogen receptor alpha protein in an estradiol-resistant, tamoxifen-sensitive human endometrial adenocarcinoma grown in nude mice. Gynecol Oncol 2002;84:271-279.
41. Desai AJ, Luqmani YA, Walters JE, et al.: Presence of exon 5-deleted oestrogen receptor in human breast cancer: Functional analysis and clinical significance. Br J Cancer 1997;75:1173-1184.